Gordon, K., K. Papp, M. Gooderham, A. Morita, P. Foley, D. Tha?i, S. Kundu, R. Kisa, L. Wei, and S. Banergee. “BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s28, doi:10.25251/skin.4.supp.28.